My watch list
my.bionity.com  
Login  

Contrast Agents

News Contrast Agents

  • Chemistry breakthrough sheds new light on illness and health

    From microscopes to MRI scanners, imaging technology is growing ever more vital in the world's hospitals, whether for the diagnosis of illness or for research into new cures. Imaging technology requires dyes or contrast agents of some sort. Current contrast agents and dyes are expensive, difficult t more

  • Two-in-One Imaging Agents

    Accurate visualization of living systems is key to the correct diagnosis and effective treatment of many diseases, as well as an improved understanding of biological processes. Magnetic resonance imaging (MRI) is a popular non-invasive visualization technique, which requires a possibly toxic contras more

  • Bayer launches Betaferon in China

    Bayer Schering Pharma announced the upcoming launch in China of Betaferon® (interferon beta-1b) for the treatment of relapsing-remitting forms of multiple sclerosis (MS). Betaferon is already approved in over 100 countries worldwide. With Betaferon and Gadovist®1.0, which was also recently launched more

All news on contrast agents

Publications Contrast Agents

All publications on contrast agents

Market studies Contrast Agents

  • Hungary Pharmaceuticals and Healthcare Report Q2 2012

    BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical market, representing moderately good news for drugmakers. However, this development will only delay the impact on drugmakers operating in the market until 2012; in reality, it has only pus more

  • Guerbet Group (GBT) - Financial and Strategic SWOT Analysis Review

    Guerbet Group (Guerbet) is a pharmaceutical company engaged in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. Guerbet provides a wide range of contrast agents for X-ray examinations, Magnetic Resonance Imaging (MRI)and nuclear medicine. Additionall more

  • Bracco S.p.A. - Strategic SWOT Analysis Review

    Bracco S.p.A. (Bracco) is a healthcare company that primarily focuses on diagnostic imaging. Bracco develops optimized contrast agents for a variety of application fields including X-rays, Magnetic Resonance, Ultrasound, and Nuclear Medicine. The company was established in 1927 and is represented in more

All market studies on contrast agents

Websites Contrast Agents

ir_news_07Dec_2009.html

>   HOME >   CONTACT CORPORATE Profile Leadership In the News Careers RESEARCH Technology Market Indications Publications PRODUCT DEVELOPMENT Development Status Davunetide intranasal Davunetide intravenous Pre-clinical Partnering INVESTOR RELATIONS News Releases Investment Highlights Shareholder Rep more

Cytos Biotechnology - Glossaryof Biological Terms

News Events Overview Rationale for Immunodrugs™ Strategy Board & Management Industry Collaborations Letter of the CEO History Overview Immunodrug™ Platform Immunodrug™ Manufacturing Scientific Collaborations Scientific Publications Pipeline Clinical Trials Disease Areas Overview Board & Management S more

Publications

deutsch Company About us History People Contact Pictures Products MegaStokes-Dyes Blue Excitation Green Excitation Orange Excitation Red Excitation Far Red Excitation NIR Excitation Others Product search Application Microscopy Microarrays in vivo Imaging Imaging FRET Publications Downloads Links Com more

All websites on contrast agents

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE